Fyn kinase inhibition as a novel therapy for Alzheimer’s disease

Haakon B Nygaard , Christopher H van Dyck and Stephen M Strittmatter

Alzheimer's Research & Therapy 2014, 6:8 (5 February 2014)

Strittmatter and colleagues review the putative signalling pathway of amyloid-beta and discuss evidence that implicates tyrosine kinase Fyn in the pathogenesis of Alzheimer's disease, through its interaction with both amyloid-beta and tau.

Subscription required

All research articles in Alzheimer's Research & Therapy are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help